Xenex
Founded 2009 Β· 3 known investors
Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections. The company sells to hospital infection control programs as part of a device-plus-service offering.
HealthtechMedical DevicesRobotics
Founders & leadership
Xenex was founded in 2009 by Mark (Tuck) Stibich, Julie Stachowiak, Morris Miller, and Mark "Tuck" Stibich.
M(
Mark (Tuck) StibichCo-founder
JS
Julie StachowiakCo-founder
MM
M"
Mark "Tuck" StibichFounder & Chief Scientific Officer
Investors Β· 3
Non-dilutive funding Β· 2 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $942.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $146.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Xenex do?
- Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections. The company sells to hospital infection control programs as part of a device-plus-service offering.
- Who founded Xenex?
- Xenex was founded by Mark (Tuck) Stibich, Julie Stachowiak, Morris Miller, Mark "Tuck" Stibich in 2009.
- Who are Xenex's investors?
- Xenex's investors include Battery Ventures, Targeted Technology Funds, Tectonic Ventures.